100 Active Studies

Sarcoma Clinical Trials Near You

Find 100 actively recruiting sarcoma research studies near you. Connect with study sites, check eligibility, and explore new treatment options.

100Active Trials
107+Locations
32,017Participants Needed

Recruiting Studies

Advanced Search

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Top Cities for Sarcoma Clinical Trials

Sarcoma clinical trials are recruiting across 107 cities. Here are the cities with the most active studies:

Sarcoma Trial Phases

PHASE2(49 studies)
PHASE1(34 studies)
NA(9 studies)
PHASE3(7 studies)

53 research organizations are sponsoring sarcoma trials.

About Sarcoma

Sarcomas are rare cancers that arise in bone and soft tissues including muscle, fat, blood vessels, and connective tissue. There are more than 70 subtypes of sarcoma. Treatment usually involves surgery combined with radiation and/or chemotherapy.

Clinical trials are advancing new treatments for sarcoma. Currently, 100 studies are recruiting a combined 32,017 participants across the United States. Research is being conducted by 53 organizations including National Cancer Institute (NCI), Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Memorial Sloan Kettering Cancer Center and 50 others.

2026 Sarcoma Research Landscape

As of July 2026, the sarcoma clinical trial landscape includes 100 actively recruiting studies across 107 cities in the United States. These studies are collectively seeking 32,017 participants, with an average enrollment target of 320 per study.

The research spans multiple phases of development: 49 studies are in PHASE2, 34 studies are in PHASE1, 9 studies are in NA, 7 studies are in PHASE3. The presence of Phase 3 trials indicates that some sarcoma treatments are in late-stage testing and may be approaching regulatory review.

Research is being led by 53 different organizations, including National Cancer Institute (NCI), Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Memorial Sloan Kettering Cancer Center, Vanderbilt-Ingram Cancer Center, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, and 48 others. The large number of sponsors reflects significant research interest and investment in sarcoma treatment advancement.

Geographically, sarcoma trials are most concentrated in Los Angeles, California (19 trials); Houston, Texas (18 trials); New York, New York (16 trials); Boston, Massachusetts (10 trials); Aurora, Colorado (10 trials) and 7 other cities.

Featured Sarcoma Studies

Highlighted recruiting studies for sarcoma, selected by enrollment size and research scope.

RecruitingNCT01109394

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Background: \- Laboratory investigators who are studying common childhood cancers are interested in developing a tissue repository to collect and store blood, serum, tissue, urine, or tumors of children who have cancer or adults who have common childhood cancers. To develop this repository, additional samples will be collected from children and adults who have been diagnosed with common childhood...

Sponsor: National Cancer Institute (NCI)· 6,035 participants· 5 locations (Washington D.C., Orange, Bethesda, New York)
View full study details →
RecruitingNCT07129317

Pediatric Radiation Therapy Registry

The Johns Hopkins Pediatric Radiation Oncology Program is creating a registry that will capture the full 3D radiation dosimetry delivered to its pediatric patients to manage the quality of care provided, as well as to examine the long-term outcomes and toxicity of each patient. The registry will capture baseline clinical data, disease, toxicity, and quality of life outcomes. The goal is to include...

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins· 5,000 participants· 2 locations (Washington D.C., Baltimore)
View full study details →
RecruitingNCT00579566

Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma

The purpose of this study is to study normal and sarcoma cells. To study these cells we need to have human tissue. You will be having or have already had a procedure to remove tissue. We would like to use some of this tissue. We will use it for laboratory studies on the diagnosis,behavior and treatment of sarcoma. We will perform an extensive analysis of your samples. We will only use extra tissue...

Sponsor: Memorial Sloan Kettering Cancer Center· 3,000 participants· 7 locations (Basking Ridge, Middletown, Montvale, Commack)
View full study details →

Frequently Asked Questions About Sarcoma Clinical Trials

Are there sarcoma clinical trials near me?

Yes, there are 100 sarcoma clinical trials currently recruiting across 107+ cities in the United States, including Los Angeles, California; Houston, Texas; New York, New York. Browse the studies above to find one at a location convenient for you.

How do I join a sarcoma clinical trial?

To join a sarcoma clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.

Are sarcoma clinical trials free?

Yes, participation in sarcoma clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.

What types of sarcoma treatments are being studied?

Current sarcoma clinical trials are testing a range of approaches across PHASE2 (49 studies), PHASE1 (34 studies), NA (9 studies), PHASE3 (7 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 53 research organizations.

Is it safe to participate in sarcoma clinical trials?

Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.

Data updated July 16, 2026 from ClinicalTrials.gov

About This Data

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.

Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.

Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov